John Galgiani Archives

DxNA and TGen submit Valley Fever test for FDA approval

DxNA LLC, a molecular diagnostics company, today announced the 510(k) submission to the U.S. Food and Drug Administration (FDA) of its molecular diagnostics assay using its proprietary GeneSTAT System and GeneSTAT Coccidiodes molecular test for rapid detection of Coccidiomycosis (Valley Fever). The Valley Fever assay on the GeneSTAT System, upon clearance by the FDA, provides for… Read More →

UA Valley Fever Center produces treatment booklet

The Valley Fever Center for Excellence at the University of Arizona has developed a reference booklet that includes all of the facts that physicians and other health-care professionals need about Valley Fever, including how to diagnose it and what to do when a new infection is discovered. While this information has existed for many years, it now… Read More →

Arizona bioscience industry producing ‘aha’ moments

AZBio Expo 2014 had “aha moments” at every turn. With over 250 entrepreneurs, innovators, business leaders, legislators, scientists and researchers in attendance, the energy was sizzling and the outlook endless. Here are just a few of the event highlights, appropriately, A to Z: A – Access to Capital is the key. No money. No honey.… Read More →